Endogenous cardiotonic steroids and differential patterns of sodium pump inhibition in NaCl-loaded salt-sensitive and normotensive rats

American Journal of Hypertension

Volumn 22, Issue 5, 2009, Pages 559-563

  Bagrov, Alexei Y ^a   Agalakova, Natalia I ^a   Kashkin, Vladimir A ^a   Fedorova, Olga V ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM) INHIBITOR; ATRIAL NATRIURETIC FACTOR; CARDIOTONIC AGENT; CYCLIC GMP; MARINOBUFAGENIN; SODIUM CHLORIDE; STEROID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DAHL SALT SENSITIVE RAT; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME RELEASE; HYPERTENSION; KIDNEY MEDULLA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; SCIENTIFIC LITERATURE; SODIUM EXCRETION; SODIUM RETENTION; SODIUM URINE LEVEL; SPRAGUE DAWLEY RAT; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

ANIMALS; BUFANOLIDES; CARDIAC GLYCOSIDES; CYCLIC GMP; KIDNEY; MALE; MUSCLE, SMOOTH, VASCULAR; OUABAIN; RATS; RATS, INBRED DAHL; RATS, SPRAGUE-DAWLEY; SODIUM; SODIUM CHLORIDE, DIETARY; SODIUM-POTASSIUM-EXCHANGING ATPASE;

EID: 67349140905     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2009.22     Document Type: Article

References (30)

1. Weinberger MH. Sodium and blood pressure 2003. Curr Opin Cardiol 2004; 19:353-356.
2. Meneton P, Jeunemaitre X, de Wardener HE, MacGregor GA. Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases. Physiol Rev 2005; 85:679-715.
3. Haddy FJ, Overbeck HW. The role of humoral agents in volume expanded hypertension. Life Sci 1976; 19:935-947.
4. Blaustein MP. Sodium ions, calcium ions, blood pressure regulation, and hypertension: a reasessment and a hypothesis. Am J Physiol 1977; 232: C165-C173.
5. Bagrov AY, Shapiro JI. Endogenous digitalis: pathophysiologic roles and therapeutic applications. Nature Clin Pract Nephrol 2008; 4:378-392.
6. Blanco G, Mercer RW. Isozymes of the Na-K-ATPase: heterogeneity in structure, diversity in function. Am J Physiol 1998; 275:F633-F650.
7. Bagrov AY, Fedorova OV, Dmitrieva RI, Howald WN, Hunter AP, Kuznetsova EA, Shpen VM. Characterization of a urinary bufodienolide Na+,K+-ATPase inhibitor in patients after acute myocardial infarction. Hypertension 1998; 31:1097-1103.
8. Komiyama Y, Dong XH, Nishimura N, Masaki H, Yoshika M, Masuda M, Takahashi H. A novel endogenous digitalis, telocinobufagin, exhibits elevated plasma levels in patients with terminal renal failure. Clin Biochem 2005; 38:36-45.
9. Fedorova OV, Kolodkin NI, Agalakova NI, Lakatta EG, Bagrov AY. Marinobufagenin, an endogenous α-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats. Hypertension 2001; 37:462-426.
10. Fedorova OV, Lakatta EG, Bagrov AY. Endogenous Na,K pump ligands are differentially regulated during acute NaCl loading of Dahl rats. Circulation 2000; 102:3009-3014.
11. Fedorova OV, Kolodkin NI, Agalakova NI, Namikas AR, Bzhelyansky A, St-Louis J, Lakatta EG, Bagrov AY. Antibody to marinobufagenin lowers blood pressure in pregnant rats on a high NaCl intake. J Hypertens 2005; 23:835-842.
12. Knudsen KD, Iwai J, Heine M, Leitl G, Dahl LK. Genetic influence on the development of renal hypertension in parabiotic rats. Evidence that a humoral hypertensinogenic factor is produced in kidney tissue of hypertension-prone rats. J Exp Med 1969; 130:1353-1365.
13. Fedorova OV, Talan MI, Agalakova NI, Lakatta EG, Bagrov AY. An endogenous ligand of α-1 sodium pump, marinobufagenin, is a novel mediator of sodium chloride dependent hypertension. Circulation 2002; 105:1122-1127.
14. Periyasamy SM, Liu J, Tanta F, Kabak B, Wakefield B, Malhotra D, Kennedy DJ, Nadoor A, Fedorova OV, Gunning W, Xie Z, Bagrov AY, Shapiro JI. Salt loading induces redistribution of the plasmalemmal Na/K-ATPase in proximal tubule cells. Kidney Int 2005; 67:1868-1877.
15. Anderson DE, Fedorova OV, Morrell CH, Longo DL, Kashkin VA, Metzler JD, Bagrov AY, Lakatta EG. Endogenous sodium pump inhibitors and age-associated increases in salt sensitivity of blood pressure in normotensives. Am J Physiol Regul Integr Comp Physiol 2008; 294:R1248-R1254.
16. Fedorova OV, Agalakova NI, Morrell CH, Lakatta EG, Bagrov AY. ANP differentially modulates marinobufagenin-induced sodium pump inhibition in kidney and aorta. Hypertension 2006; 48:1160-1168.
17. Fedorova OV, Agalakova NI, Talan MI, Lakatta EG, Bagrov AY. Brain ouabain stimulates peripheral marinobufagenin via angiotensin II signaling in NaClloaded Dahl-S rats. J Hypertens 2005; 23:1515-1523.
18. Fedorova OV, Zhuravin IA, Agalakova NI, Yamova LA, Talan MI, Lakatta EG, Bagrov AY. Intrahippocampal microinjection of an exquisitely low dose of ouabain mimics NaCl loading and stimulates a bufadienolide Na/K-ATPase inhibitor. J Hypertens 2007; 25:1834-1844.
19. Fedorova OV, Anderson DE, Lakatta EG, Bagrov AY. Interaction of NaCl and behavioral stress on endogenous sodium pump ligands in rats. Am J Physiol Regul Integr Comp Physiol 2001; 281:R352-R358.
20. Fotis H, Tatjanenko LV, Vasilets LA. Phosphorylation of the α-subunits of the Na,ATPase from mammalian kidneys and Xenopus oocytes by cGMP-dependent protein kinase results in stimulation of ATPase activity. Eur J Biochem 1999; 260:904-910.
21. Scavone C, Scanlon C, McKee M, Nathanson JA. Atrial natriuretic peptide modulates sodium and potassium activated adenosine triphosphothase through a mechanism involving cyclic GMP and cyclic GMP-dependent protein kinase. J Pharmacol Exper Ther 1995; 272:1036-1043.
22. Gupta G, Azam M, Yang L, Danziger RS. The β2 subunit inhibits stimulation of the α1/β1 form of soluble guanylyl cyclase by nitric oxide. Potential relevance to regulation of blood pressure. J Clin Invest 1997; 100:1488-1492.
23. Sasser JM, Sullivan JC, Elmarakby AA, Kemp BE, Pollock DM, Pollock JS. Reduced NOS3 phosphorylation mediates reduced NO/cGMP signaling in mesenteric arteries of deoxycorticosterone acetate-salt hypertensive rats. Hypertension 2004; 43:1080-1085.
24. Simchon S, Manger W, Blumberg G, Brensilver J, Cortell S. Impaired renal vasodilation and urinary cGMP excretion in Dahl salt-sensitive rats. Hypertension1996; 27:653-657.
25. Simchon S, Manger WM, Carlin RD, Peeters LL, Rodriguez J, Batista D, Brown T, Merchant NB, Jan KM, Chien S. Salt-induced hypertension in Dahl salt-sensitive rats. Hemodynamics and renal responses. Hypertension 1989; 13:612-621.
26. Itoh H, Nakao K, Mukoyama M, Yamada T, Hosoda K, Shirakami G, Morii N, Sugawara A, Saito Y, Shiono S, Arai H, Ikuyo Yoshida I, Imura H. Chronic blockade of endogenous atrial natriuretic polypeptide (ANP) by monoclonal antibody against ANP accelerates the development of hypertension in spontaneously hypertensive and deoxycorticosterone acetate-salt-hypertensive rats. J Clin Invest1989; 84:145-154.
27. Melo LG, Veress AT, Chong CK, Pang SC, Flynn TG, Sonnenberg H. Salt-sensitive hypertension in ANP knockout mice: potential role of abnormal plasma renin activity. Am J Physiol 1998; 274:R255-R261.
28. Quaschning T, D'Uscio LV, Shaw S, Gröne HJ, Ruschitzka F, Lüscher TF. Vasopeptidase inhibition restores renovascular endothelial dysfunction in saltinduced hypertension. J Am Soc Nephrol 2001; 12:2280-2287.
29. Aviv R, Gurbanov K, Hoffman A, Blumberg S, Winaver J. Urinary neutral endopeptidase 24.11 activity: modulation by chronic salt loading. Kidney Int 1995; 47:855-860.
30. Lee J. Reciprocal regulation of angiotensin converting enzyme and neutral endopeptidase in rats with experimental hypertension. Physiol Res 2004; 53: 365-368.